Angiotensin II induces cholesterol accumulation and impairs insulin secretion by regulating ABCA1 in beta cells[S]

In pancreatic β cells, ABCA1, a 254 kDa membrane protein, affects cholesterol homeostasis and insulin secretion. Angiotensin II, as the main effector of the renin–angiotensin system, decreases glucose-stimulated insulin secretion (GSIS). We examined the effect of angiotensin II on ABCA1 expression in primary pancreatic islets and INS-1 cells. Angiotensin II decreased ABCA1 protein and mRNA; angiotensin II type 1 receptor (AT1R) blockade rescued this ABCA1 repression. In parallel, angiotensin II suppressed the promoter activity of ABCA1, an effect that was abrogated by PD98095, a specific inhibitor of MAPK kinase (MEK). LXR enhanced ABCA1 promoter activity, and angiotensin II decreased the nuclear abundance of LXR protein. On a chromatin immunoprecipitation assay, LXR mediated the transcription of ABCA1 by directly binding to its promoter. Mutation of the LXR binding site on the ABCA1 promoter cancelled the effect of angiotensin II. Furthermore, angiotensin II induced cholesterol accumulation and impaired GSIS; inhibition of AT1R or MEK pathway reversed these effects. In summary, our study showed that angiotensin II suppressed ABCA1 expression in pancreatic islets and INS-1 cells, indicating that angiotensin II may influence GSIS by regulating ABCA1 expression. Additional research may address therapeutic needs in diseases such as diabetes mellitus.

• Publication year

  2018

• Venue

  Journal of Lipid Research

• Publication date

  2018-08-14

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1194/jlr.M085886PMID 30108153PMCID PMC6168299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis

  2017cited by this paper
• Insulin-like Growth Factor 1 Regulates the Expression of ATP-Binding Cassette Transporter A1 in Pancreatic Beta Cells

  2016cited by this paper
• Inhibition of ERK1/2 and Activation of LXR Synergistically Reduce Atherosclerotic Lesions in ApoE-Deficient Mice

  2015cited by this paper
• Angiotensin-(1-7) stimulates cholesterol efflux from angiotensin II-treated cholesterol-loaded THP-1 macrophages through the suppression of p38 and c-Jun N-terminal kinase signaling.

  2015cited by this paper
• ABCA1 in adipocytes regulates adipose tissue lipid content, glucose tolerance, and insulin sensitivity[S]

  2014cited by this paper
• Angiotensin II Regulates Islet Microcirculation and Insulin Secretion in Mice

  2014cited by this paper
• HNF4&agr; Increases Liver-Specific Human ATP-Binding Cassette Transporter A1 Expression and Cholesterol Efflux to Apolipoprotein A-I in Response to Cholesterol Depletion

  2012cited by this paper
• PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway.

  2012cited by this paper
• Exendin-4 regulates the expression of the ATP-binding cassette transporter A1 via transcriptional factor PREB in the pancreatic β cell line

  2011cited by this paper
• Exendin-4 regulates the expression of the ATP-binding cassette transporter A1 via transcriptional factor PREB in the pancreatic β cell line

  2011cited by this paper
• Transcriptional factor prolactin regulatory element-binding protein-mediated gene transcription of ABCA1 via 3',5'-cyclic adenosine-5'-monophosphate.

  2010cited by this paper
• Liver X receptor in cholesterol metabolism.

  2010cited by this paper
• Exendin-4 regulates pancreatic ABCA1 transcription via CaMKK/CaMKIV pathway

  2009cited by this paper
• Impaired insulin secretion in four Tangier disease patients with ABCA1 mutations.

  2009cited by this paper
• Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes.

  2009cited by this paper
• A protocol for islet isolation from mouse pancreas

  2009cited by this paper
• Cholesterol in islet dysfunction and type 2 diabetes.

  2008cited by this paper
• ATP-binding cassette transporter A1 gene transcription is downregulated by activator protein 2alpha. Doxazosin inhibits activator protein 2alpha and increases high-density lipoprotein biogenesis independent of alpha1-adrenoceptor blockade.

  2007cited by this paper
• Sterol Regulatory Element-binding Protein-2- and Liver X Receptor-driven Dual Promoter Regulation of Hepatic ABC Transporter A1 Gene Expression

  2007cited by this paper
• ATP-Binding Cassette Transporter A1 Gene Transcription Is Downregulated by Activator Protein 2&agr;: Doxazosin Inhibits Activator Protein 2&agr; and Increases High-Density Lipoprotein Biogenesis Independent of &agr;1-Adrenoceptor Blockade

  2007cited by this paper
• Regulation of Scavenger Receptor Class BI Gene Expression by Angiotensin II in Vascular Endothelial Cells

  2007cited by this paper
• β-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment

  2007cited by this paper
• Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and beta-cells.

  2007cited by this paper
• Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes.

  2006cited by this paper
• Platelet derived growth factor regulates ABCA1 expression in vascular smooth muscle cells

  2006cited by this paper
• Transcriptional Repression of ATP-Binding Cassette Transporter A1 Gene in Macrophages: A Novel Atherosclerotic Effect of Angiotensin II

  2005cited by this paper
• Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes.

  2005cited by this paper
• Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets

  2004cited by this paper
• Angiotensin II activates MAP kinase and NF-kappaB through angiotensin II type I receptor in human pancreatic cancer cells.

  2004cited by this paper
• The role of calcium/calmodulin-dependent protein kinase cascade in glucose upregulation of insulin gene expression.

  2004cited by this paper
• Lipid-dependent bidirectional traffic of apolipoprotein B in polarized enterocytes.

  2003cited by this paper
• Promoter-Specific Roles for Liver X Receptor/Corepressor Complexes in the Regulation of ABCA1 and SREBP1 Gene Expression

  2003cited by this paper
• The Zinc Finger Protein 202 (ZNF202) Is a Transcriptional Repressor of ATP Binding Cassette Transporter A1 (ABCA1) and ABCG1 Gene Expression and a Modulator of Cellular Lipid Efflux*

  2001cited by this paper
• Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells.

  2000cited by this paper
• Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.

  2000cited by this paper
• International union of pharmacology. XXIII. The angiotensin II receptors.

  2000cited by this paper
• Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor.

  2000cited by this paper
• How MAP Kinases Are Regulated (*)

  1995cited by this paper
• Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans.

  1995cited by this paper
• Angiotensin II signal transduction and the mitogen-activated protein kinase pathway.

  1995cited by this paper
• Molecular physiology of reverse cholesterol transport.

  1995cited by this paper
• Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications

  1995cited by this paper
• Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells.

  1992cited by this paper
• The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product.

  1992cited by this paper
• Insulin secretion and the morphological and metabolic characteristics of pancreatic islets of hyperthyroid ob/ob mice.

  1978cited by this paper

• TLR4 mediates lipotoxic β-cell dysfunction by inhibiting the TMEM24/PI3K/AKT pathway

  2025cites this paper
• Rescuing vascular dysfunction in dorsal pancreatic arteries prevents tacrolimus-induced glucose metabolism disorder in mice

  2025cites this paper
• NMDA Suppresses Pancreatic ABCA1 Expression through the MEK/ERK/LXR Pathway in Pancreatic Beta Cells

  2024influential citation
• Interplay of Angiotensin Peptides, Vasopressin, and Insulin in the Heart: Experimental and Clinical Evidence of Altered Interactions in Obesity and Diabetes Mellitus

  2024cites this paper
• Alterations of Whole-Body Glucose Metabolism in a Feline SARS-CoV-2 Infection Model.

  2024cites this paper
• Impact of Delta SARS-CoV-2 Infection on Glucose Metabolism: Insights on Host Metabolism and Virus Crosstalk in a Feline Model

  2024cites this paper
• High glucose dialysate-induced peritoneal fibrosis: Pathophysiology, underlying mechanisms and potential therapeutic strategies.

  2023cites this paper
• HDL maturation and remodelling.

  2022cites this paper
• Effects of 2-Methoxyestradiol, a Main Metabolite of Estradiol on Hepatic ABCA1 Expression in HepG2 Cells

  2022cites this paper
• Remembering your A, B, C's: Alzheimer's disease and ABCA1

  2022cites this paper
• Molecular mechanisms for ABCA1-mediated cholesterol efflux

  2022cites this paper
• Captopril and Spironolactone Can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting ABCA1 and microRNA-33.

  2022cites this paper
• Cholesterol Metabolism in Chronic Kidney Disease: Physiology, Pathologic Mechanisms, and Treatment.

  2022cites this paper
• Adipose Tissue Secretion Pattern Influences β-Cell Wellness in the Transition from Obesity to Type 2 Diabetes

  2022cites this paper
• The mechanisms of renin-angiotensin system in hepatocellular carcinoma: From the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures.

  2021cites this paper
• Activation of RAS contributes to peritoneal fibrosis via dysregulation of low-density lipoprotein receptor.

  2021cites this paper
• Divalent Metal Transporter 1 Knock-Down Modulates IL-1β Mediated Pancreatic Beta-Cell Pro-Apoptotic Signaling Pathways through the Autophagic Machinery

  2021cites this paper
• Oxidized LDL Downregulates ABCA1 Expression via MEK/ERK/LXR Pathway in INS-1 Cells

  2021cites this paper
• Integrated Datasets of Proteomic and Metabolomic Biomarkers to Predict Its Impacts on Comorbidities of Type 2 Diabetes Mellitus

  2020cites this paper
• The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities

  2020cites this paper
• Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes

  2020cites this paper
• The Nuclear Export and Ubiquitin-Proteasome-Dependent Degradation of PPARγ Induced By Angiotensin II

  2019cites this paper
• The association of calcium channel blockers with β‐cell function in type 2 diabetic patients: A cross‐sectional study

  2019cites this paper